FDA Clearance Tracker · P150026-S014
HeartLight Catheter, HeartLight X3 Console V2
Last checked: Nov 20, 2026Latest source record: Feb 24, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Feb 24, 2023
Approved
Time to decision
308 days
Received Apr 22, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150026-S014
- Device name
- HeartLight Catheter, HeartLight X3 Console V2
- Applicant
- Cardiofocus, Inc.
- Applicant location
- Marlborough, MA
- Received
- Apr 22, 2022
- Decided
- Feb 24, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150026
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for changes to the Console of the HeartLight System.
Source documents
Other decisions for Cardiofocus, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P150026 · Decided Apr 1, 2016 · 246 days after receipt
Device type: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation (OAE) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.